Gilead Sciences Inc Insider Profile

4 Followers
Gilead Sciences Inc, Ten Percent Owner at Achillion Pharmaceuticals, holds 1.12M shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds 13.91M shares in Arcus Biosciences (Ticker: RCUS). Most recently, Gilead Sciences Inc ― shares of Achillion Pharmaceuticals on ― for an estimated value of ―.
Gilead Sciences Inc

Gilead Sciences Inc
Achillion Pharmaceuticals (~ACHN)
Ten Percent Owner

Not Ranked
Gilead Sciences Inc has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$229M
100.00%
A breakdown of Gilead Sciences Inc's holdings

Insider Roles

Arcus Biosciences
(RCUS)
Ten Percent Owner
Roles that Gilead Sciences Inc holds in companies

Most Profitable Insider Trade

Stock:
Arcus Biosciences
(RCUS)
Rating:Informative Buy
Date:Feb 02, 2021 - Feb 02, 2022
Return:-22.40%
The most profitable trade made by Gilead Sciences Inc

Gilead Sciences Inc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ACHN
Achillion Pharmaceuticals
$7.54M
Arcus Biosciences
Feb 02, 2021
Ten Percent Owner
Informative Buy
$220.35M
$228.87M
List of latest transactions for each holding click on a transaction to see Gilead Sciences Inc's performance on stock

Gilead Sciences Inc insider profile FAQ

What is the percentage of profitable transactions made by Gilead Sciences Inc?
The percentage of profitable transactions made by Gilead Sciences Inc is ―.
    What is the average return per transaction made by Gilead Sciences Inc?
    The average return per transaction made by Gilead Sciences Inc is ―.
      What stocks does Gilead Sciences Inc hold?
      Gilead Sciences Inc holds: ~ACHN, RCUS stocks.
        What was Gilead Sciences Inc’s latest transaction?
        Gilead Sciences Inc latest transaction was an Uninformative Buy of ―.
          What was Gilead Sciences Inc's most profitable transaction?
          Gilead Sciences Inc’s most profitable transaction was an Informative Buy of RCUS stock on February 2, 2021. The return on the trade was -22.40%.
            What is Gilead Sciences Inc's role in Achillion Pharmaceuticals?
            Gilead Sciences Inc's role in Achillion Pharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.